Your browser doesn't support javascript.
loading
A case report of a malignant melanoma in the cardiologic diagnostic workup.
Jahnke, Constantin; Gramlich, Robert; Sander, Christian; Willems, Stephan; Chung, Da-Un.
Afiliação
  • Jahnke C; Department of Cardiology and Critical Care Medicine, Asklepios Klinik St. Georg, Lohmühlenstraße 5, 20099 Hamburg, Germany.
  • Gramlich R; German Centre for Cardiovascular Research DZHK, Partner Site Hamburg, Hamburg, Germany.
  • Sander C; Department of Cardiology and Critical Care Medicine, Asklepios Klinik St. Georg, Lohmühlenstraße 5, 20099 Hamburg, Germany.
  • Willems S; Eduard-Arning-Klinik for Dermatology & Allergology, Asklepios Klinik St. Georg, Hamburg, Germany.
  • Chung DU; Department of Cardiology and Critical Care Medicine, Asklepios Klinik St. Georg, Lohmühlenstraße 5, 20099 Hamburg, Germany.
Eur Heart J Case Rep ; 8(7): ytae312, 2024 Jul.
Article em En | MEDLINE | ID: mdl-39021359
ABSTRACT

Background:

Cardiovascular imaging plays an important role in identifying pre-existing cardiac comorbidity prior to the decision on cancer therapy and serves as a reference for detecting changes during treatment and long-term follow-up and also in the further identification of a possible cardiac manifestation of the underlying oncological disease. Case

summary:

We report the case of an 81-year-old patient with a malignant melanoma. The patient initially was presented before the start of adjuvant therapy with serine/threonine-protein kinase B-Raf/mitogen-activated extracellular signal-regulated kinase inhibitors. Cardiologic staged diagnostics using transthoracic echocardiography, transoesophageal echocardiography, and cardiovascular magnetic resonance imaging (CMR) revealed with a high probability a cardiac manifestation of the underlying disease. The echocardiographic and CMR results as well as the diagnostic workup are presented.

Discussion:

Cardiac masses in general have a variety of differential diagnoses. Cardiac metastases are much more common than primary neoplasms in a ratio of about 101. Cardiovascular risk stratification is recommended in all patients with cancer before starting potentially cardiotoxic anticancer therapy. Cardiovascular imaging plays an important role for baseline risk stratification but is also the leading diagnostic tool in the differential diagnosis of cardiac tumours and the planning of a potential therapy.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article